Decreased plasma nesfatin-1 levels in patients with generalized anxiety disorder
dc.contributor.author | Gunay, Huseyin | |
dc.contributor.author | Tutuncu, Recep | |
dc.contributor.author | Aydin, Suleyman | |
dc.contributor.author | Dag, Ersel | |
dc.contributor.author | Abasli, Dilek | |
dc.date.accessioned | 2020-06-25T17:52:24Z | |
dc.date.available | 2020-06-25T17:52:24Z | |
dc.date.issued | 2012 | |
dc.department | Kırıkkale Üniversitesi | |
dc.description.abstract | Nesfatin-1, a recently discovered satiety molecule, is localized in neurons of the hypothalamus and brain stem and colocalized with stress-related substances. However, the relation between nesfatin-1 and stressor related behaviors like anxiety and/or fear has not yet been investigated in human subjects. In the present study, our aim was to investigate whether there was a relationship between plasma nesfatin-1 levels and generalized anxiety disorder. The study group consisted of 40 patients (BMI, 22.98 +/- 0.56) with generalized anxiety disorder and 34 age-matched healthy male control subjects (23.05 +/- 0.4). Patients fully met the fourth Diagnostic and Statistical Manual of Mental Disorders, text revision. Blood samples for nesfatin-1 were drawn at the end of an overnight fasting period at least 10 h. Plasma nesfatin-1 levels were measured and found significantly lower in anxiety disorder group than in control group (0.35 +/- 0.037 ng/ml vs. 0.63 +/- 0.080 ng/ml, respectively, p < 0.05). Low nesfatin-1 levels may be related with generalized anxiety disorder. (C) 2012 Elsevier Ltd. All rights reserved. | en_US |
dc.identifier.citation | closedAccess | en_US |
dc.identifier.doi | 10.1016/j.psyneuen.2012.04.007 | |
dc.identifier.endpage | 1953 | en_US |
dc.identifier.issn | 0306-4530 | |
dc.identifier.issue | 12 | en_US |
dc.identifier.pmid | 22595767 | |
dc.identifier.scopus | 2-s2.0-84869866502 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 1949 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.psyneuen.2012.04.007 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12587/5151 | |
dc.identifier.volume | 37 | en_US |
dc.identifier.wos | WOS:000312511000006 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Pergamon-Elsevier Science Ltd | en_US |
dc.relation.ispartof | Psychoneuroendocrinology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Generalized anxiety disorder | en_US |
dc.subject | Plasma nesfatin-1 | en_US |
dc.subject | Satiety | en_US |
dc.title | Decreased plasma nesfatin-1 levels in patients with generalized anxiety disorder | en_US |
dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1
[ X ]
- İsim:
- Decreased plasma nesfatin-1 levels in patients with generalized anxiety disorder.pdf
- Boyut:
- 260.47 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin/Full Text